Form 4: Vivani Medical Director Alexandra Popoff Granted 35,135 Stock Options

Vivani Medical, Inc. Director Alexandra L. Popoff was granted 35,135 non-qualified stock options with an exercise price of $1.27 per share as part of her annual compensation.

Summary

• Alexandra L. Popoff, a Director of Vivani Medical, Inc. (VANI), was granted 35,135 non-qualified stock options.
• The options have an exercise price of $1.27 per share.
• The grant date for the transaction was June 24, 2025.
• These options were awarded as an annual grant under the Issuer's Non-Employee Director Compensation Policy.
• The options will vest in full on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, provided continued service.
• The options expire on June 23, 2035.

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a standard compensation practice that aligns interests with shareholders, generally viewed as a neutral to slightly positive event as it indicates ongoing commitment and standard governance.

Positives

• The grant of stock options aligns the director's interests with those of shareholders, as the options gain value if the stock price increases.
• It indicates a standard compensation practice for non-employee directors, reflecting ongoing commitment to corporate governance.

Negatives

• No direct negatives are apparent from this specific Form 4 filing, as it represents a standard compensation event.

Risks

• The value of the stock options is subject to the future performance of Vivani Medical, Inc.'s common stock, meaning the options could become worthless if the stock price falls below the exercise price.

Future Outlook

The options are subject to a vesting schedule, which will occur on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, contingent on continued service.

Industry Context

This Form 4 filing reflects a routine equity compensation event for a non-employee director, common across publicly traded companies to align director incentives with shareholder value. It does not provide broader industry trends or competitive insights.

Comparison to Industry Standards

• This document does not provide sufficient information to compare the compensation structure or option grant details to specific comparable companies or industry benchmarks. The grant of stock options to directors is a standard practice in corporate governance across various industries.

Corporate Governance

Related Party Transactions

• The grant of 35,135 non-qualified stock options to Alexandra L. Popoff, a director of Vivani Medical, Inc., constitutes a related party transaction as it involves compensation provided by the company to a member of its board.

Stakeholder Impact

• Shareholders: The option grant aligns the director's financial interests with shareholder value creation, as the options become more valuable if the stock price increases.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• The options will vest on the earlier of June 24, 2026 (first anniversary of grant) or the date of the next annual meeting of stockholders.
• Alexandra L. Popoff must continue her service as a director through the vesting date to receive the options.

Key Dates

Recommendation

Keywords

Vivani Medical, VANI, Stock Option Grant, Director Compensation, SEC Form 4, Insider Transaction, Equity Compensation, Non-Qualified Stock Option